Allied Market Research

Intravenous (IV) Ibuprofen Market Expected to Reach $0.015 billion By 2030


Report Code : A01078

quote Alarming rise in prevalence of bone cancer, rise in number of hospitals, and easy availability of ibuprofen intravenous (IV) injections are expected to notably contribute toward the growth of the global intravenous (IV) ibuprofen market during the forecast period quote

Onkar Sumant
Manager, Healthcare at Allied Market Research

Get 20% Free Customization In This Report
Follow us on Social Media:       

According to a new report published by Allied Market Research, titled, Intravenous (IV) Ibuprofen Market by Indication and Age Group: Global Opportunity Analysis and Industry Forecast, 2021–2030", the global intravenous (IV) ibuprofen market size was valued at $5.34  million in 2020, and is projected to reach $15.48 million by 2030, registering a CAGR of 13.4% from 2021 to 2030.

The intravenous (IV) ibuprofen is used to treat mild to severe pain and inflammation. The ibuprofen belongs to non-steroidal anti-inflammatory drugs (NSAIDs) class of drugs. Ibuprofen acts by inhibiting cyclooxygenase (COX 1 and COX 2), which is required for the production of prostaglandins (PG). Prostaglandins (PG) are responsible for pain and inflammation.

Factors that drive the growth of the intravenous (IV) ibuprofen market include, rise in number of hospitals, increase in prevalence of bone cancer, and pediatric population. For instance, according to the State of Americas Children, in 2021, it was reported that there were around 73 million children present in the U.S., as the use of ibuprofen injection in children was approved Furthermore, increase in number of product approvals and product launch in new markets contribute in the growth of the market.

The intravenous (IV) ibuprofen market is segmented on the basis of indication, age group, and region

Depending on indication, the market is bifurcated into pain/inflammatory and fever. The pain/inflammatory segment was the major revenue contributor in 2020, owing to the prevalence of mucoskelatal diseases.

On the basis of age group, the IV ibuprofen market is categorized into digital pediatrics and adults. The adults segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to the prevalence of headache and muscle pain in adults.

Impact of COVID-19 Pandemic on Intravenous (IV) Ibuprofen Market (Pre & Post Analysis)

The COVID-19 outbreak is anticipated to have a negative impact on the growth of the intravenous (IV) ibuprofen market as most hospitals are not operating due to COVID-19 and the ongoing lockdowns in many countries. The COVID-19 virus has serious and life-threatening impact on population. However, a huge number of clinics and hospitals across the globe were restructured to increase the hospital capacity to provide better healthcare facility, and this is expected to increase the diagnosis and treatment of bone cancer, which contributes in the market growth.

Key Findings Of Study

  • On the basis of indication, the pain/inflammatory segment was the highest contributor to the market in 2020.
  • On the basis of age group, the adults segment dominated the market in 2020.
  • Region-wise, U.S. garnered the largest revenue share in 2020, whereas China is anticipated to grow at the highest CAGR during the forecast period.

North America accounted for a majority of the global IV ibuprofen market share in 2020, and is anticipated to remain dominant during the forecast period, due to rise in prevalence of bone cancer, presence of key players for development of IV ibuprofen medication, and well-established infrastructure in the region. Asia-Pacific is anticipated to witness lucrative growth, owing to the prevalence of arthritis and high population in region, owing to increase in the number of hospitals, prevalence of cancer, and high pediatric population base.

Need More Information

pr-det-talk Talk to David (Europe)

pr-det-talk Talk to Sona Padman (Americas)

5933 NE Win Sivers Drive #205,
Portland, OR 97220 United States

pr-det-phone Toll Free: +1-800-792-5285

pr-det-phone UK: +44-845-528-1300

pr-det-phone Hong Kong: +852-301-84916

pr-det-phone India (Pune): +91 2066346060

pr-det-phone Fax: +1(855) 550-5975



For Media Inquiries, Please Contact

Tushar Nagose
Communications Officer
Allied Market Research
Contact Toll Free: +1-800-792-5285
Drop us an email at


First time buyer?
Check offers and discount on this report
To get this report

Click Here

quote Intravenous (IV) Ibuprofen Market by Indication (Pain/Inflammatory and Fever) and Age Group (Pediatrics and Adults): Global Opportunity Analysis and Industry Forecast, 2021-2030 quote

View Report
Avenue Video Loading...

Avenue: Entire Library membership of Allied Market Research Reports at your disposal

  • Avenue is an innovative subscription-based online report database.
  • Avail an online access to the entire library of syndicated reports on more than 4,222 niche industries and company profiles on more than 12,953 firms across 11 domains.
  • A cost-effective model tailored for entrepreneurs, investors, and students & researchers at universities.
  • Request customizations, suggest new reports, and avail analyst support as per your requirements.
  • Get an access to the library of reports at any time from any device and anywhere.


Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to provide pertinent information and save time of readers


Featured Readings


Published Date Jan 2021

Surgical Equipment Market

Download Sample

Published Date Nov 2020

Medical Implant Market

Download Sample

Get Fresh content delivered

Get insights on topics that matter to your business. Stay updated on the area that interests you.

Get Industry Data Alerts

Buy Full Version
"Intravenous (IV) Ibuprofen Market"
Purchase Enquiry